DBV Technologies S.A. Operating Expenses 2011-2026 | DBVT

Annual Operating Expenses DBV Technologies S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
121 M	92.2 M	101 M	104 M	135 M	152 M	166 M	145 M	116 M	45.6 M	39 M	20 M	13.6 M	7.32 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
166 M	7.32 M	89.9 M

Quarterly Operating Expenses DBV Technologies S.A.

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
42.6 M	27.4 M	31.4 M	35 M	30 M	20.6 M	27.4 M	23.4 M	-	20.1 M	25.4 M	19.3 M	-	25.7 M	29.6 M	32.6 M	-	33.9 M	51.3 M	45.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
51.3 M	19.3 M	30.7 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Aptorum Group Limited APM	20.7 M	$ 0.81	0.15 %	$ 4.42 M	China
argenx SE ARGX	2.27 B	$ 836.39	-0.46 %	$ 25 B	Niderland
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Ascendis Pharma A/S ASND	338 M	$ 234.52	-0.2 %	$ 5 B	Danmark
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.44	3.42 %	$ 8.28 B	Australia
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
BioVie BIVI	18.1 M	$ 1.24	-0.8 %	$ 1.83 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
BioMarin Pharmaceutical BMRN	1.47 B	$ 61.58	-1.66 %	$ 11.7 B	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Atea Pharmaceuticals AVIR	193 M	$ 4.56	-1.94 %	$ 384 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Capricor Therapeutics CAPR	49.3 M	$ 28.24	1.18 %	$ 756 M	USA
Axsome Therapeutics AXSM	99.1 M	$ 165.14	-2.83 %	$ 8.22 B	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
CASI Pharmaceuticals CASI	38.9 M	$ 0.31	-61.59 %	$ 42.2 M	USA
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Catalyst Biosciences CBIO	176 M	$ 12.21	-3.48 %	$ 804 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Biogen BIIB	5.39 B	$ 191.78	-1.72 %	$ 28.1 B	USA
Bellicum Pharmaceuticals BLCM	28.5 M	-	-9.72 %	$ 5.89 M	USA
Baudax Bio BXRX	54.6 M	-	0.59 %	$ 63 K	USA
Aptose Biosciences APTO	26.3 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Aridis Pharmaceuticals ARDS	23.4 K	-	17.91 %	$ 11.1 M	USA
BioNTech SE BNTX	512 M	$ 110.5	-0.35 %	$ 27.2 B	Germany
Amneal Pharmaceuticals AMRX	539 M	$ 14.64	-0.17 %	$ 4.52 B	USA